Exit this survey Hepatitis Question Title * 1. Firstly, could you please indicate in which European country you are based? Austria. Belgium. Bulgaria. Croatia. Cyprus. Czech Republic. Denmark. Estonia. Finland. France. Germany. Greece. Hungary. Ireland. Italy. Latvia. Lithuania. Luxembourg. Malta. Netherlands. Norway. Poland. Portugal. Romania. Slovakia. Slovenia. Spain. Sweden. Switzerland. United Kingdom. Question Title * 2. Which is your area of expertise? Clinician Nurse Public Health Expert Academic/researcher Patient Organization representative Accompanying person Press Other Other (please specify) Question Title * 3. Immunization programs for Hepatitis B.Has your country included Hepatitis B in their Universal Vaccination program? Has your country implemented additional programmes for risk groups? (Please select all that apply) Universal Vaccination (routine Infant vaccination) Yes No I do not know Universal Vaccination (routine Infant vaccination) menu Neonate born to HBsAg + mothers Yes No I do not know Neonate born to HBsAg + mothers menu Health Care Workers Yes No I do not know Health Care Workers menu Commercial Sex Workers Yes No I do not know Commercial Sex Workers menu Partners to and persons living with HBV-infected persons Yes No I do not know Partners to and persons living with HBV-infected persons menu IDU Yes No I do not know IDU menu Men that have sex with men Yes No I do not know Men that have sex with men menu Prison Population Yes No I do not know Prison Population menu Question Title * 4. Have public campaigns been run in your country about VIRAL HEPATITIS and its risks during the last 12 months? (Such campaigns could be on TV, on the radio, or in newspapers.)[Please specify only one option.] a) Yes. b) Not in the last 12 months, but during the last few years. c) Yes, but further back in time than a few years ago. d) No, to my knowledge, we have never had such a campaign in my country. e) I do not remember / I do not know. Question Title * 5. Are there leaflets about viral hepatitis in health care centers?[Please specify only one option.] a) Yes, easy to find in every health care center. b) Not in every center but in some. c) I have not seen such leaflets in any healthcare centers. d) I do not know. Question Title * 6. Post exposure immunization for hepatitis B[Please specify only one option.] a) Yes, available for free to everyone (recommended) in need. b) Available to everyone but paid privately for “non occupational exposure” c) Not available or only available for health care staff d) I do not know Question Title * 7. Annual HCV antibody testing for HIV- infected persons with continued high-risk behaviors,(such as Injection Drugs Users and Men who have Sex with Men)[Please specify only one option.] a) Yes, offered at least once a year b) Less than once a year but regularly c) Yes, but not regular at all. d) Never e) I do not know Question Title * 8. Screening HBV/HCV funding[Please specify only one option.] a) 100 % subsidized, i.e. free of charge to the individual (= no co-payment) b) Same subsidy (co-payment) as other similar treatments in our public healthcare system c) A lower subsidy (higher co-payment) than other similar treatments d) We have to pay 100% privately. e) I do not know Other (please specify) Question Title * 9. Are HBV vaccinations:[Please specify only one option.] a) 100 % subsidized, i.e. free of charge to the individual (= no co-payment) b) Same subsidy (co-payment) as other similar treatments in our public healthcare system c) A lower subsidy (higher co-payment) than other similar treatments d) Patients have to pay 100% privately e) I do not know Other (please specify) Question Title * 10. Are HEPATITIS-RELATED DRUGS (including prescription drugs) on the same terms as the drugs taken by people who have other medical conditions?[Please specify only one option.] a)They have special status (higher subsidy = lower co-payment than other patients, or for drugs not related to hepatitis) b) They enjoy drug subsidies on the same terms as other patients or for other drugs. c) Some drugs, essential for hep patients have a lower subsidy than common prescription drugs. e) I do not know Other (please specify) Question Title * 11. How long is the waiting time for specialist appointment?[Please specify only one option.] a) In the same week. b) Between one and two weeks. c) More than two weeks but less than a month d) More than a month e) I do not know Other (please specify) Question Title * 12. Is Genotyping a (free) regular practice in your country?[Please specify only one option.] HCV HBV a) Yes, to all chronic patients before they start their treatments a) Yes, to all chronic patients before they start their treatments HCV a) Yes, to all chronic patients before they start their treatments HBV b) Yes to all chronic patients before they start their treatments but it is not for free b) Yes to all chronic patients before they start their treatments but it is not for free HCV b) Yes to all chronic patients before they start their treatments but it is not for free HBV e) It is not a regular practice. e) It is not a regular practice. HCV e) It is not a regular practice. HBV f) I do not know f) I do not know HCV f) I do not know HBV Additional comment Question Title * 13. % of children treated in a specialist unit?[Please specify only one option.] a) All b) Only some of them or in some areas or regions c) Only very few or we do not have specialist unit for children Question Title * 14. Adherence to European (EASL} guidelines (Hep B, Hep C} a) 100% b) About 50% c) We follow national society guidelines or others d) I do not know Additional comment Question Title * 15. Do you have Hepatitis specialist nurses in your country? (Means with clinical accreditation)[Please specify only one option.] a) Yes, widely available in the country b) Only available in some hospitals c) None or very few. d) I do not know additional comment Question Title * 16. In your experience, which % of drop-outs occurs during treatment?[Please specify only one option.] HBV HCV Less than 10% Less than 10% HBV Less than 10% HCV Between 10 and 30% Between 10 and 30% HBV Between 10 and 30% HCV Between 30 – 50% Between 30 – 50% HBV Between 30 – 50% HCV More than 50% More than 50% HBV More than 50% HCV I do not know I do not know HBV I do not know HCV Question Title * 17. Is there an HCC registry?[Please specify only one option.] a) Yes, national b) Yes, regional c) Only in some regions d) Only some hospitals e) None f) I do not know Other (please specify) Question Title * 18. Is there a HCV/HBV (general hepatitis; liver) patient organization in your country? [Please specify only one option.] a) National b) Regional c) I do not know Question Title * 19. Is there National funding for Hepatitis strategy in your country?[Please specify only one option.] a) Yes b) No, the strategy was privately funded c) We do not have a National strategy d) I do not know Done